CXBS — Corix Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Corix Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2013 January 31st	2014 January 31st	2015 January 31st	2015 December 31st	C2016 December 31st
Period Length:	—	12 M	12 M	12 M	—
Source:	10-Q	10-K	10-K	10-K	10-Q
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0	0	0	0.2	0.002
Net Total Receivables	—	—	—	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0	0.001	0	0.2	0.238
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	9	0.005
Other Long Term Assets
Total Assets	0	0.001	0	9.42	11.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.017	0.024	0	4.37	1.07
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.017	0.024	0	4.95	6.89
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.017	-0.023	0	4.47	4.48
Total Liabilities & Shareholders' Equity	0	0.001	0	9.42	11.4
Total Common Shares Outstanding